This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked IBTK Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-IBTK WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~150.5 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Oral mucosa (IHC candidate; verify WB) |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The A07985 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A07985) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A07985) |
| Primary antibody | A07985 · 1:1000 (catalog A07985) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A07985) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A07985) |
IBTK is predicted at 150.5 kDa; isoforms and phosphorylation could affect migration, but no empirical band or demonstrated shift is supplied.
| Band near 150.5 kDa | Consistent with the predicted IBTK mass; confirm identity with antibody controls. |
| Multiple bands near the expected region | Could reflect isoforms 1, 2, and 3; their migration differences are unknown. |
| Slightly shifted band or doublet | Could reflect phosphorylation; a visible shift is not established. |
| Reduced cytoplasmic band after IgM stimulation | Consistent with IBTK translocation to the plasma membrane. |
| UniProt predicted mass | Places the reference protein near 150.5 kDa. |
| Isoform 1 | Its individual mass and migration are not supplied. |
| Isoform 2 | Alternative splicing may change migration, but its size is unspecified. |
| Isoform 3 | Alternative splicing may change migration, but its size is unspecified. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | IBTK may redistribute to the plasma membrane after IgM stimulation, or detection may be insufficient. | Check membrane and cytoplasmic fractions and verify antibody detection with a positive control. |
| Band higher than expected | Phosphorylation could affect migration, but the size of any shift is unknown. | Compare phosphatase-treated material and confirm band identity with a second antibody. |
| Band lower than expected | An alternatively spliced isoform is possible; isoform masses are unavailable. | Confirm identity with an independent antibody or isoform-specific sample. |
| Multiple bands | IBTK has three named isoforms and documented phosphorylation sites; distinct bands are not established. | Compare isoform-specific samples or phosphatase-treated material and confirm antibody specificity. |
| Weak or no signal | IgM-dependent redistribution may reduce IBTK in a sampled fraction. | Check whole-cell and membrane fractions alongside a positive control. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | Medium | Protein (IHC) | HPA → |
| Cervix | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Oral mucosa | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Not detected | Protein (IHC) | HPA → |
| Soft tissue | chondrocytes | Not detected | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Not detected | Protein (IHC) | HPA → |
| Vagina | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for IBTK, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A07985 is a human-reactive anti-IBTK antibody with a Western blot image from cell-line extracts. The supplied record reports a 1:1000 primary dilution and 25 µg protein per lane; it provides no publication or independent validation evidence.
Which to pick: A07985 is the only listed IBTK antibody. It has a Western blot image and reported human reactivity; use the stated 1:1000 dilution as a starting point for your samples.